
Asteroids Pharmaceutical Private Limited
About Asteroids Pharmaceutical Private Limited
Data last updated:
Asteroids Pharmaceutical Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2011PTC026269. Its GSTIN is 23AAJCA6619D1ZY (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Vikas Khandelwal and Shirin Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 202 – C First Floor Ganesh Market Dawa Bazar 13 – 14 R.N.T. Marg, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2025, the company reported a revenue of ₹73.17 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹71,450 (net margin 1%) and EBITDA of ₹5.4 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Asteroids Pharmaceutical Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. 202 – C First Floor Ganesh Market Dawa Bazar 13 – 14 R.N.T. Marg, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Asteroids Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Asteroids Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Asteroids Pharmaceutical Private Limited, buy the company report.
Financials of Asteroids Pharmaceutical Private Limited
FY 2025 filings availableAsteroids Pharmaceutical Private Limited reported revenue of ₹73.17 Lakh (up 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 36% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹71,450 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Asteroids Pharmaceutical Private Limited, buy the company report.
Board of directors of Asteroids Pharmaceutical Private Limited
Asteroids Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Khandelwal Also directs: Eureka Lifesciences Private Limited | Director | 28 Jun 2011 | 15 Years 4 Months | Current |
| Shirin Gupta Also directs: Eureka Lifesciences Private Limited | Director | 28 Jun 2011 | 15 Years 4 Months | Current |
Peer comparison
Asteroids Pharmaceutical Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| V.R. Medi Drugs Private Limited | ₹73.33 Lakh (FY 2025) | 1.0% | Uttar Pradesh, India | |||
| Ambromide Pharma Private Limited | ₹73.21 Lakh (FY 2025) | -41.0% | Manimajra, Chandigarh, India | |||
| N Lexo Pharma Private Limited | ₹73.19 Lakh (FY 2024) | 383.0% | Gandhinagar, Gujarat, India | |||
| Asteroids Pharmaceutical Private Limitedthis company | ₹73.17 Lakh (FY 2025) | ₹71,450 | 1% | 36.0% | Indore, Madhya Pradesh, India | |
| Abia Pharmaceuticals Private Limited | ₹73.13 Lakh (FY 2024) | -70.0% | Chennai, Tamil Nadu, India | |||
| Pci Bioscience Private Limited | ₹73.08 Lakh (FY 2024) | -14.0% | Mandi Adampur, Haryana, India | |||
| Caraway Pharma Private Limited | ₹72.97 Lakh (FY 2021) | -54.0% | Madurai, Tamil Nadu, India |
To see the full peer comparison of Asteroids Pharmaceutical Private Limited, buy the company report.
Auditor
Asteroids Pharmaceutical Private Limited is audited by ASHISH K VYAS & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHISH K VYAS & CO | FY 2021 | 010411C |
Shareholding
The shareholding of Asteroids Pharmaceutical Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Asteroids Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Asteroids Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Asteroids Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Asteroids Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAJCA6619D1ZY | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Asteroids Pharmaceutical Private Limited, buy the company report.
Recent activity
Asteroids Pharmaceutical Private Limited has 2 board changes on record since 2011: 2 appointments. The latest: Shirin Gupta was appointed as Director on 28 Jun 2011.
Frequently asked questions
Asteroids Pharmaceutical is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 June 2011 (15+ years old) and is registered under CIN U24232MP2011PTC026269.
Asteroids Pharmaceutical has 2 current directors:
- Vikas Khandelwal - Director
- Shirin Gupta - Director
The latest financial statements of Asteroids Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Asteroids Pharmaceutical is 23AAJCA6619D1ZY, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Asteroids Pharmaceutical is U24232MP2011PTC026269. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Asteroids Pharmaceutical was incorporated on 28 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Asteroids Pharmaceutical by revenue are V.R. Medi Drugs Private Limited, Ambromide Pharma Private Limited, N Lexo Pharma Private Limited, Abia Pharmaceuticals Private Limited, Pci Bioscience Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Shirin Gupta was appointed as Director on 28 Jun 2011. Vikas Khandelwal was appointed as Director on 28 Jun 2011.
The registered office of Asteroids Pharmaceutical is at Shop No. 202 – C First Floor Ganesh Market Dawa Bazar 13 – 14 R.N.T. Marg, Indore, Madhya Pradesh, India – 452001.
Asteroids Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Asteroids Pharmaceutical is compliant as of 17 August 2026. The company is actively filing with the Registrar of Companies.

